Trial intelligence / Profile preview

Effect of knee bone mineral density on Migu Capsule treatment for knee osteoarthritis

ChiCTR2000039587Phase 4Recruiting

Sponsor
Shanghai Baoshan Hospital of Integrated Chinese and Western Medicine
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Migu in knee osteoarthritis (OA) (2 arms), sponsored by Shanghai Baoshan Hospital of Integrated Chinese and Western Medicine. Primary endpoint: WOMAC scale for knee joint function. Started Jan 2020; status: recruiting.

02

Drugs

Migu
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR2000039587.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039587.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call